Infectious Diseases

Search for publications

Only original articles, editorials, guidelines.

  • Cascajero A, Rastrojo A, Díez-Fuertes F, Hernández-Novoa B, Aguado B, Moreno S, Alcami J, Pérez-Olmeda M.

    Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.

    JOURNAL OF VIROLOGY . 92(11): . Number of citations: 2

    [doi:10.1128/JVI.00390-18]

  • Domínguez-Alegría AR, Pintado V, Barbolla I.

    Treatment and prevention of invasive pneumococcal disease.

    REVISTA CLINICA ESPANOLA . 218(5): 244-252. Number of citations: 6

    [doi:10.1016/j.rce.2018.01.004]

  • Medrano LM, Garcia-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontañón V, Muñoz-Fernández MÁ, Resino S, and the GESIDA 3603b Study Group.

    Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.

    AIDS . 32(9): 1095-1105. Number of citations: 21

    [doi:10.1097/QAD.0000000000001787]

  • Ndumbi P, Del Romero J, Pulido F, Velasco Arribas M, Dronda F, Blanco Ramos JR, García de Olalla P, Ocaña I, Belda-Ibañez J, Del Amo J, Álvarez-Del Arco D, aMASE Research Group.

    Barriers to health care services for migrants living with HIV in Spain.

    EUROPEAN JOURNAL OF PUBLIC HEALTH . 28(3): 451-457. Number of citations: 11

    [doi:10.1093/eurpub/ckx225]

  • Navarro M, Navaza B, Guionnet A, López-Vélez R.

    Overcoming Barriers to HIV Prevention and Healthcare Among Sub-Saharan African Migrants in Spain.

    Jmir Public Health And Surveillance . 4(2): 10478-10478.

    [doi:10.2196/10478]

  • Llop M, Sifuentes WA, Bañón S, Macia-Villa C, Perez-Elías MJ, Rosillo M, Moreno S, Vázquez M, Casado JL.

    Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age.

    Archives Of Osteoporosis . 13(1): 56-56. Number of citations: 6

    [doi:10.1007/s11657-018-0464-2]

  • Madrid-Elena N, García-Bermejo ML, Serrano-Villar S, Díaz-de Santiago A, Sastre B, Gutiérrez C, Dronda F, Coronel Díaz M, Domínguez E, López-Huertas MR, Hernández-Novoa B, Moreno S.

    Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-?B Activation in Resting CD4 + T Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.

    JOURNAL OF VIROLOGY . 92(9): . Number of citations: 32

    [doi:10.1128/JVI.01931-17]

  • Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

    Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 24 Suppl 1: .

    [doi:10.1016/j.cmi.2018.01.002]

  • Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Asensi V, Crespo M, Domingo P, Iribarren JA, Lázaro P, López-Aldeguer J, Lozano F, Martínez E, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, Gatell JM.

    Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 36(5): 268-276. Number of citations: 5

    [doi:10.1016/j.eimc.2017.04.002]

  • Cervero M, Torres R, Agud JL, Alcázar V, Jusdado JJ, García-Lacalle C, Moreno S.

    Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients.

    Plos One . 13(4): . Number of citations: 11

    [doi:10.1371/journal.pone.0196201]

  • Miró G, López-Vélez R.

    Clinical management of canine leishmaniosis versus human leishmaniasis due to Leishmania infantum: Putting One Health principles into practice.

    VETERINARY PARASITOLOGY . 254: 151-159. Number of citations: 20

    [doi:10.1016/j.vetpar.2018.03.002]

  • Pérez-Latorre L, Sánchez-Conde M, Miralles P, López JC, Parras F, Tejerina F, Aldámiz-Echevarría T, Carrero A, Díez C, Ramírez M, Gutiérrez I, Bellón JM, Bañares R, Berenguer J.

    Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis.

    BMC INFECTIOUS DISEASES . 18(1): 170-170. Number of citations: 1

    [doi:10.1186/s12879-018-3067-z]

  • Petersen E, Petrosillo N, Koopmans M, ESCMID Emerging Infections Task Force Expert Panel.

    Emerging infections-an increasingly important topic: review by the Emerging Infections Task Force.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 24(4): 369-375. Number of citations: 23

    [doi:10.1016/j.cmi.2017.10.035]

  • Herrador Z, Fernandez-Martinez A, Benito A, Lopez-Velez R.

    Clinical Cysticercosis epidemiology in Spain based on the hospital discharge database: What's new?

    PLOS NEGLECTED TROPICAL DISEASES . 12(4): . Number of citations: 4

    [doi:10.1371/journal.pntd.0006316]

  • Vivancos MJ, Moreno S.

    Are toxicities of current nucleosides still a concern?

    The lancet. HIV . 5(4): 156-157.

    [doi:10.1016/S2352-3018(18)30022-5]

  • Crespillo-Andújar C, Calbacho Robles M, Norman FF, Pérez-Molina JA.

    Severe immune thrombocytopaenia in a patient taking benznidazole for chronic Chagas disease.

    BMJ case reports . 2018: .

    [doi:10.1136/bcr-2017-223788]

  • Muñoz P, Vena A, Machado M, Gioia F, Martínez-Jiménez MC, Gómez E, Origüen J, Orellana MÁ, López-Medrano F, Fernández-Ruiz M, Merino P, González-Romo F, Frías I, Pérez-Granda MJ, Aguado JM, Fortún J, Bouza E, T2MadRid study group.

    T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.

    The Journal of antimicrobial chemotherapy . 73(suppl_4): 6-12. Number of citations: 35

    [doi:10.1093/jac/dky047]

  • Muñoz P, Vena A, Machado M, Martínez-Jiménez MC, Gioia F, Gómez E, Origüen J, Orellana MÁ, López-Medrano F, Pérez-Granda MJ, Aguado JM, Fortún J, Bouza E, T2MadRid study group.

    T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study.

    The Journal of antimicrobial chemotherapy . 73(suppl_4): 13-19. Number of citations: 21

    [doi:10.1093/jac/dky048]